TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
ORGO

Organogenesis Holdings Inc

Healthcare · Drug Manufacturers - Specialty & Generic

1.40$ -2.4% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement ORGO
Line item 2001 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% – – 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
114.7% 46.9% – – 35.6% 29.1% 25.8% 24.4% 23.3% 24.6% 24.0% 24.4%
-14.7% 53.1% – – 64.4% 70.9% 74.2% 75.6% 76.7% 75.4% 76.0% 75.6%
151.6% 3.9% – – 5.6% 5.7% 5.9% 6.6% 8.8% 10.2% 10.4% 7.9%
79.7% 0.0% – – 83.7% 76.1% 59.3% 52.4% 61.9% 61.1% 60.3% 57.9%
346.0% 125.8% – – 89.3% 82.3% 66.3% 60.1% 71.8% 72.5% 76.3% 65.7%
-246.0% 0.0% – – -26.7% -11.4% 7.9% 15.5% 4.9% 2.9% -0.3% 9.9%
0.0% 0.0% – – 5.6% 3.4% 3.3% 1.5% 0.4% 0.5% 0.3% 0.4%
-276.5% 0.0% – – -33.5% -14.8% 5.3% 13.5% 4.5% 2.4% -0.6% 8.3%
0.0% -0.2% – – 0.0% 0.1% 0.2% -6.7% 1.1% 1.3% -0.8% 1.8%
-276.5% 0.0% – – -33.5% -14.8% 5.1% 20.2% 3.4% 1.1% 0.2% 6.6%
– – – – -24.3% -7.6% 11.0% 18.6% 8.9% 8.3% 3.3% 13.1%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?